Madopar 125 mg tablete
| Name | Madopar 125 mg tablete |
|---|---|
| Former Name | Madopar 125 tablete |
| Marketing Authorisation Number | HR-H-771762650 |
| Active Substance | levodopa benzerazidklorid |
| Composition | jedna tableta sadržava 100 mg levodope i 25 mg benzerazida u obliku benzerazidklorida |
| Pharmaceutical Form | tableta |
| Manufacturer | Roche Pharma AG, Grenzach-Wyhlen, Njemačka |
| Marketing Authorisation Holder | Roche d.o.o., Ulica grada Vukovara 269a, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.06.2015 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/337 |
| Registration Number | 381-12-01/70-15-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BA02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
